A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery

Immunocompromised patients often fail to raise protective vaccine-induced immunity against the global emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Although monoclonal antibodies have been authorized for clinical use, most have lost their ability to potently neu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Benjakul, Sopisa, Anthi, Aina Karen, Kolderup, Heidi Anette, Vaysburd, Marina, Lode, Heidrun Elisabeth, Mallery, D, Fossum, Even, Vikse, Elisabeth Lea, Albecka, Anna, Ianevski, Aleksandr, Kaynov, Denis, Karlsen, Karine Flem, Sakya, Siri Aastedatter, Nyquist-Andersen, Mari, gjølberg, torleif, Moe, Morten Carsten, Bjørås, Magnar, Sandlie, Inger, James, Leo C, Andersen, Jan Terje
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!